B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co

$ 18.99

4.7
(581)
In stock
Description

Joint marketing of CytoSorb® with B. Braun’s newest OMNI® blood purification platform will offer greater access of this advanced treatment of deadly inflammation to critically ill patients. MELSUNGEN, Germany and MONMOUTH JUNCTION, N.J., March 2, 2021 /PRNewswire/ — B. Braun Avitum AG, a leading manufacturer of medical devices and pharmaceutical products and services and CytoSorbents Corporation […]

biohaveninvestorpresenta

Organization

EANS-Tip Announcement: Hypo Vorarlberg Bank AG / Yearly financial

B. Braun and CytoSorbents Announce Global Co-Marketing Agreement

In this image released on Tuesday, March 2, 2021, the OMNI

B. Braun Melsungen AG Accelerates Digital Healthcare Innovations with MuleSoft - Salesforce

Velocity Global's 2022 Work In Progress Report: Businesses and talent benefit from

Velocity Global's 2022 Work In Progress Report: Businesses and

THE Arab Bank for Economic Development in Africa (BADEA) RECEIVES